{"id":11242,"date":"2023-10-10T15:51:17","date_gmt":"2023-10-10T18:51:17","guid":{"rendered":"https:\/\/passarini.com.br\/publication-rdc-810-modifies-rdc751\/"},"modified":"2023-10-11T17:18:10","modified_gmt":"2023-10-11T20:18:10","slug":"importance-of-anvisa-innovation-policy","status":"publish","type":"post","link":"https:\/\/passarini.com.br\/en\/importance-of-anvisa-innovation-policy\/","title":{"rendered":"The Importance of ANVISA&#8217;s Innovation Policy for the Development of the Healthcare Sector in Brazil"},"content":{"rendered":"<p><div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-1 hundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"--awb-background-position:left center;--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-padding-top:0px;--awb-padding-right:0px;--awb-padding-bottom:0px;--awb-padding-left:0px;--awb-margin-top:0px;--awb-margin-bottom:0px;--awb-flex-wrap:wrap;\" ><div class=\"fusion-builder-row fusion-row\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-0 fusion_builder_column_1_1 1_1 fusion-one-full fusion-column-first fusion-column-last\" style=\"--awb-padding-top:0px;--awb-padding-right:0px;--awb-padding-bottom:0px;--awb-padding-left:0px;--awb-bg-size:cover;--awb-margin-bottom:0px;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\"><div class=\"fusion-slider-sc fusion-flexslider-loading flexslider flexslider-hover-type-none\" data-slideshow_autoplay=\"1\" data-slideshow_smooth_height=\"0\" data-slideshow_speed=\"7000\" style=\"max-width:100%;height:100%;\"><ul class=\"slides\"><li class=\"image\"><span class=\"fusion-image-hover-element hover-type-none\"><img decoding=\"async\" src=\"https:\/\/passarini.com.br\/wp-content\/uploads\/2020\/10\/1920x500_informativos_noticias-1.webp\" alt=\"Banner Informativos Blog da Passarini\" width=\"1560\" height=\"406\" class=\"wp-image-8654\" \/><\/span><\/li><\/ul><\/div><div class=\"fusion-clearfix\"><\/div><\/div><\/div><\/div><\/div><div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-2 nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-padding-top:10px;--awb-flex-wrap:wrap;\" ><div class=\"fusion-builder-row fusion-row\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-1 fusion_builder_column_3_4 3_4 fusion-three-fourth fusion-column-first\" style=\"--awb-bg-size:cover;width:75%;width:calc(75% - ( ( 4% ) * 0.75 ) );margin-right: 4%;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\"><div class=\"fusion-text fusion-text-1\"><h2 class=\"headingpostinterno\">Anvisa&#8217;s Innovation Policy: What It Is and How It Can Impact the Healthcare Sector in Brazil.<\/h2>\n<p>Innovation in health is an increasingly relevant topic for the development of the sector and the improvement of the population&#8217;s quality of life. Therefore, it is important to be aware of initiatives aimed at promoting and supporting healthcare innovation in Brazil, such as ANVISA&#8217;s Innovation Policy, which was recently published.<\/p>\n<p>ANVISA&#8217;s Innovation Policy is a set of regulatory actions that aim to promote health innovation in the country by encouraging the development of innovative, safe, and effective products and services. The policy is based on four strategic pillars: regulatory environment conducive to innovation, articulation and cooperation with relevant stakeholders, knowledge and information management, and an organizational culture focused on innovation.<\/p>\n<\/div><div class=\"fusion-text fusion-text-2\"><p>The first pillar refers the creaction of a regulatory environment that favors innovation in health, through the adoption of measures such as simplifying processes, making requirements more flexible, reducing deadlines, prioritizing demands, incorporating new technologies and methodologies, assessing regulatory impact, and periodic review of current standards.<\/p>\n<p>The second pillar refers to articulation and cooperation with relevant actors to health innovation, such as government agencies, representative entities of the regulated sector, educational and research institutions, international organizations, foreign regulatory agencies, and civil society. The objective is to promote dialogue, exchange, technical cooperation, and alignment of interests among different actors.<\/p>\n<p>The third pillar refers to the management of knowledge and information about health innovation through the production, dissemination, use, and updating data, information, and scientific evidence that support regulatory decisions and guide agentes involved in healthcare innovation. The objective is to increase access to information, strengthen the technical and scientific capacity of ANVISA and other actors, and also foment an evidence-based culture.<\/p>\n<p>The fourth pillar refers to the organizational culture focused on innovation at <a href=\"https:\/\/en.wikipedia.org\/wiki\/Brazilian_Health_Regulatory_Agency\">ANVISA<\/a> , through the development of competencies, skills, and attitudes that stimulate creative thinking, experimentation, continuous learning, adaptation to change, risk tolerance, tolerance for errors, collaboration, and sharing of ideas among the agency&#8217;s employees. The objective is to create an environment favorable to innovation within ANVISA.<\/p>\n<\/div><div class=\"fusion-text fusion-text-3\"><p>he policy also defines ANVISA\u2019s principles, guidelines, objectives, and responsibilities in implementing the policy, which involves several technical areas of the agency, as well as representatives from the regulated sector, academia, government, and civil society. The initiative is part of ANVISA&#8217;s 2020-2023 Action Plan, which has as one of its strategic goals to foment innovation in health in the country.<\/p>\n<p>ANVISA&#8217;s Innovation Policy is an important milestone for strengthening the health innovation ecosystem in Brazil, which can bring benefits to patients, healthcare professionals, public and private managers, researchers, entrepreneurs, and investors. Passarini Group closely monitors updates about the policy and supports initiatives that aim to boost health innovation in Brazil.<\/p>\n<p>To find out more about ANVISA&#8217;s Innovation Policy, <a href=\"http:\/\/he policy also defines ANVISA\u2019s principles, guidelines, objectives, and responsibilities in implementing the policy, which involves several technical areas of the agency, as well as representatives from the regulated sector, academia, government, and civil society. The initiative is part of ANVISA's 2020-2023 Action Plan, which has as one of its strategic goals to foment innovation in health in the country. ANVISA's Innovation Policy is an important milestone for strengthening the health innovation ecosystem in Brazil, which can bring benefits to patients, healthcare professionals, public and private managers, researchers, entrepreneurs, and investors. Passarini Group closely monitors updates about the policy and supports initiatives that aim to boost health innovation in Brazil. To find out more about ANVISA's Innovation Policy, access the link below:\">access the link below:<\/a><\/p>\n<\/div><div class=\"fusion-sep-clear\"><\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"margin-left: auto;margin-right: auto;width:100%;\"><\/div><div class=\"fusion-sep-clear\"><\/div><div class=\"fusion-image-element in-legacy-container\" style=\"--awb-margin-top:50px;--awb-margin-bottom:50px;--awb-caption-title-font-family:var(--h2_typography-font-family);--awb-caption-title-font-weight:var(--h2_typography-font-weight);--awb-caption-title-font-style:var(--h2_typography-font-style);--awb-caption-title-size:var(--h2_typography-font-size);--awb-caption-title-transform:var(--h2_typography-text-transform);--awb-caption-title-line-height:var(--h2_typography-line-height);--awb-caption-title-letter-spacing:var(--h2_typography-letter-spacing);\"><span class=\" fusion-imageframe imageframe-none imageframe-1 hover-type-none\"><a href=\"https:\/\/passarini.com.br\/wp-content\/uploads\/2023\/08\/Feed-Noticia-ANVISA-RDC810_Passarini_Group.webp\" class=\"fusion-lightbox\" data-rel=\"iLightbox[06c78620f27c4e8b8cf]\" data-caption=\"Publica\u00e7\u00e3o da #RDC N\u00ba 810, que modifica a RDC n\u00ba 751\" data-title=\"Feed-Noticia-ANVISA-RDC810_Passarini_Group\" title=\"Blog_CONTEUDO_Politica_PT_redes_sociais_feed_story_PASSARINI\"><img decoding=\"async\" width=\"300\" height=\"300\" alt=\"Publication of #RDC No. 810 modifies RDC No. 751\" src=\"https:\/\/passarini.com.br\/wp-content\/uploads\/2023\/10\/Blog_CONTEUDO_Politica_EN_redes_sociais_feed_story_PASSARINI.webp\" class=\"img-responsive wp-image-11252\"\/><\/a><\/span><\/div><div class=\"fusion-sep-clear\"><\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"margin-left: auto;margin-right: auto;width:100%;\"><\/div><div class=\"fusion-sep-clear\"><\/div><div class=\"fusion-text fusion-text-4\"><p>For further information, please contact Passarini Group! We will be pleased to assist you via email: <span style=\"color: #0000ff;\"><strong><a style=\"color: #0000ff;\" href=\"mailto:contato@passarini.com.br?subject=Enquadramento%20de%20porte%20ANVISA\">contato@passarini.com.br<\/a><\/strong>.<\/span><\/p>\n<h2><span style=\"color: #000000;\"><strong>Passarini Group<\/strong><\/span><\/h2>\n<p>Published on: 10\/11\/2023 &#8211; Source: <a href=\"https:\/\/www.gov.br\/anvisa\/pt-br\/assuntos\/noticias-anvisa\/2023\/publicada-portaria-que-institui-a-politica-de-inovacao-da-anvisa\">ANVISA<\/a><\/p>\n<\/div><div class=\"fusion-sharing-box fusion-sharing-box-1 boxed-icons has-taglines layout-floated layout-medium-floated layout-small-stacked\" style=\"background-color:#f6f6f6;--awb-separator-border-sizes:0px;--awb-layout:row;--awb-alignment-small:space-between;--awb-stacked-align-small:center;\" data-title=\"Passarini Group\" data-description=\"Anvisa&#039;s Innovation Policy: What It Is and How It Can Impact the Healthcare Sector in Brazil.\r\nInnovation in health is an increasingly relevant topic for the development of the sector and the improvement of the population&#039;s quality of life. Therefore, it is important to be aware of initiatives aimed at promoting\" data-link=\"https:\/\/passarini.com.br\/en\/importance-of-anvisa-innovation-policy\"><h4 class=\"tagline\" style=\"color:#333333;\">To share<\/h4><div class=\"fusion-social-networks sharingbox-shortcode-icon-wrapper sharingbox-shortcode-icon-wrapper-1 boxed-icons\"><span><a href=\"https:\/\/www.facebook.com\/sharer.php?u=https%3A%2F%2Fpassarini.com.br%2Fen%2Fimportance-of-anvisa-innovation-policy&amp;t=Passarini%20Group\" target=\"_blank\" rel=\"noreferrer\" title=\"Facebook\" aria-label=\"Facebook\" data-placement=\"top\" data-toggle=\"tooltip\" data-title=\"Facebook\"><i class=\"fusion-social-network-icon fusion-tooltip fusion-facebook awb-icon-facebook\" style=\"color:#ffffff;background-color:#3b5998;border-color:#3b5998;border-radius:4px;\" aria-hidden=\"true\"><\/i><\/a><\/span><span><a href=\"https:\/\/x.com\/intent\/post?text=Passarini%20Group&amp;url=https%3A%2F%2Fpassarini.com.br%2Fen%2Fimportance-of-anvisa-innovation-policy\" target=\"_blank\" rel=\"noopener noreferrer\" title=\"X\" aria-label=\"X\" data-placement=\"top\" data-toggle=\"tooltip\" data-title=\"X\"><i class=\"fusion-social-network-icon fusion-tooltip fusion-twitter awb-icon-twitter\" style=\"color:#ffffff;background-color:#000000;border-color:#000000;border-radius:4px;\" aria-hidden=\"true\"><\/i><\/a><\/span><span><a href=\"https:\/\/www.linkedin.com\/shareArticle?mini=true&amp;url=https%3A%2F%2Fpassarini.com.br%2Fen%2Fimportance-of-anvisa-innovation-policy&amp;title=Passarini%20Group&amp;summary=Anvisa%26%2339%3Bs%20Innovation%20Policy%3A%20What%20It%20Is%20and%20How%20It%20Can%20Impact%20the%20Healthcare%20Sector%20in%20Brazil.%0D%0AInnovation%20in%20health%20is%20an%20increasingly%20relevant%20topic%20for%20the%20development%20of%20the%20sector%20and%20the%20improvement%20of%20the%20population%26%2339%3Bs%20quality%20of%20life.%20Therefore%2C%20it%20is%20important%20to%20be%20aware%20of%20initiatives%20aimed%20at%20promoting\" target=\"_blank\" rel=\"noopener noreferrer\" title=\"LinkedIn\" aria-label=\"LinkedIn\" data-placement=\"top\" data-toggle=\"tooltip\" data-title=\"LinkedIn\"><i class=\"fusion-social-network-icon fusion-tooltip fusion-linkedin awb-icon-linkedin\" style=\"color:#ffffff;background-color:#0077b5;border-color:#0077b5;border-radius:4px;\" aria-hidden=\"true\"><\/i><\/a><\/span><span><a href=\"mailto:?subject=Passarini%20Group&amp;body=https%3A%2F%2Fpassarini.com.br%2Fen%2Fimportance-of-anvisa-innovation-policy\" target=\"_self\" title=\"Email\" aria-label=\"Email\" data-placement=\"top\" data-toggle=\"tooltip\" data-title=\"Email\"><i class=\"fusion-social-network-icon fusion-tooltip fusion-mail awb-icon-mail\" style=\"color:#ffffff;background-color:#000000;border-color:#000000;border-radius:4px;\" aria-hidden=\"true\"><\/i><\/a><\/span><\/div><\/div><div class=\"fusion-clearfix\"><\/div><\/div><\/div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-2 fusion_builder_column_1_4 1_4 fusion-one-fourth fusion-column-last\" style=\"--awb-bg-size:cover;width:25%;width:calc(25% - ( ( 4% ) * 0.25 ) );\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\"><div class=\"fusion-text fusion-text-5\"><h3 data-fontsize=\"22\" data-lineheight=\"48\"><strong>More news:<\/strong><\/h3>\n<\/div><div class=\"fusion-recent-posts fusion-recent-posts-1 avada-container layout-default layout-columns-1\"><section class=\"fusion-columns columns fusion-columns-1 columns-1\"><article class=\"post fusion-column column col col-lg-12 col-md-12 col-sm-12\"><div class=\"recent-posts-content\"><span class=\"vcard\" style=\"display: none;\"><span class=\"fn\"><a href=\"https:\/\/passarini.com.br\/en\/author\/anderson\/\" title=\"Posts by Anderson Vieira\" rel=\"author\">Anderson Vieira<\/a><\/span><\/span><span class=\"updated\" style=\"display:none;\">2026-02-12T17:31:31-03:00<\/span><h4 class=\"entry-title\"><a href=\"https:\/\/passarini.com.br\/en\/siud-anvisa-udi-medical-devices-brazil-2026-deadlines\/\">SIUD Anvisa: The Complete Guide to the New UDI Database and 2026 Deadlines<\/a><\/h4><\/div><\/article><article class=\"post fusion-column column col col-lg-12 col-md-12 col-sm-12\"><div class=\"recent-posts-content\"><span class=\"vcard\" style=\"display: none;\"><span class=\"fn\"><a href=\"https:\/\/passarini.com.br\/en\/author\/anderson\/\" title=\"Posts by Anderson Vieira\" rel=\"author\">Anderson Vieira<\/a><\/span><\/span><span class=\"updated\" style=\"display:none;\">2026-02-02T16:07:37-03:00<\/span><h4 class=\"entry-title\"><a href=\"https:\/\/passarini.com.br\/en\/fda-qmsr-medical-device-regulation-update\/\">FDA Unleashes New QMSR: A Game Changer for Medical Device Quality Management<\/a><\/h4><\/div><\/article><article class=\"post fusion-column column col col-lg-12 col-md-12 col-sm-12\"><div class=\"recent-posts-content\"><span class=\"vcard\" style=\"display: none;\"><span class=\"fn\"><a href=\"https:\/\/passarini.com.br\/en\/author\/anderson\/\" title=\"Posts by Anderson Vieira\" rel=\"author\">Anderson Vieira<\/a><\/span><\/span><span class=\"updated\" style=\"display:none;\">2025-11-26T16:10:51-03:00<\/span><h4 class=\"entry-title\"><a href=\"https:\/\/passarini.com.br\/en\/simplified-process-trap-anvisa-denials-class-i-ii\/\">The Simplified Process Trap: Why Do Classes I and II Generate More Rejections at ANVISA?<\/a><\/h4><\/div><\/article><article class=\"post fusion-column column col col-lg-12 col-md-12 col-sm-12\"><div class=\"recent-posts-content\"><span class=\"vcard\" style=\"display: none;\"><span class=\"fn\"><a href=\"https:\/\/passarini.com.br\/en\/author\/anderson\/\" title=\"Posts by Anderson Vieira\" rel=\"author\">Anderson Vieira<\/a><\/span><\/span><span class=\"updated\" style=\"display:none;\">2025-11-06T10:58:24-03:00<\/span><h4 class=\"entry-title\"><a href=\"https:\/\/passarini.com.br\/en\/anvisa-new-scheduling-system-compliance-rules\/\">New ANVISA System: 3 Essential Compliance Rules and the 5-Year Risk<\/a><\/h4><\/div><\/article><article class=\"post fusion-column column col col-lg-12 col-md-12 col-sm-12\"><div class=\"recent-posts-content\"><span class=\"vcard\" style=\"display: none;\"><span class=\"fn\"><a href=\"https:\/\/passarini.com.br\/en\/author\/anderson\/\" title=\"Posts by Anderson Vieira\" rel=\"author\">Anderson Vieira<\/a><\/span><\/span><span class=\"updated\" style=\"display:none;\">2025-10-28T17:48:37-03:00<\/span><h4 class=\"entry-title\"><a href=\"https:\/\/passarini.com.br\/en\/anvisa-automates-afe-ae-end-of-waiting\/\">ANVISA Revolution: AFE and AE Are Now Automatic!<\/a><\/h4><\/div><\/article><article class=\"post fusion-column column col col-lg-12 col-md-12 col-sm-12\"><div class=\"recent-posts-content\"><span class=\"vcard\" style=\"display: none;\"><span class=\"fn\"><a href=\"https:\/\/passarini.com.br\/en\/author\/anderson\/\" title=\"Posts by Anderson Vieira\" rel=\"author\">Anderson Vieira<\/a><\/span><\/span><span class=\"updated\" style=\"display:none;\">2025-11-26T16:11:15-03:00<\/span><h4 class=\"entry-title\"><a href=\"https:\/\/passarini.com.br\/en\/devices-medical-new-export-route\/\">Devices to America: How U.S. Tariffs Are Changing Medical Device Exports<\/a><\/h4><\/div><\/article><\/section><\/div><div class=\"fusion-clearfix\"><\/div><\/div><\/div><\/div><\/div><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":16,"featured_media":11248,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[79,216,254],"tags":[69,285,284],"class_list":["post-11242","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fda-en","category-regulatorios-en","category-usa-2-en","tag-anvisa-en","tag-innovation","tag-policy"],"_links":{"self":[{"href":"https:\/\/passarini.com.br\/en\/wp-json\/wp\/v2\/posts\/11242","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/passarini.com.br\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/passarini.com.br\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/passarini.com.br\/en\/wp-json\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/passarini.com.br\/en\/wp-json\/wp\/v2\/comments?post=11242"}],"version-history":[{"count":6,"href":"https:\/\/passarini.com.br\/en\/wp-json\/wp\/v2\/posts\/11242\/revisions"}],"predecessor-version":[{"id":11265,"href":"https:\/\/passarini.com.br\/en\/wp-json\/wp\/v2\/posts\/11242\/revisions\/11265"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/passarini.com.br\/en\/wp-json\/wp\/v2\/media\/11248"}],"wp:attachment":[{"href":"https:\/\/passarini.com.br\/en\/wp-json\/wp\/v2\/media?parent=11242"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/passarini.com.br\/en\/wp-json\/wp\/v2\/categories?post=11242"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/passarini.com.br\/en\/wp-json\/wp\/v2\/tags?post=11242"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}